Evidence map›Paper›PMID 21253574›Full record

ArticlePLoS pathogens2011

Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection.

Andrea Paun, Rashmi Bankoti, Trupti Joshi, Paula M Pitha, Simona Stäger

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
6.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 74 citations in OpenAlex.

  1. The role of IRF5 as an immune regulator.Biochemical Society transactions · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Transcription Factors Interplay Orchestrates the Immune-Metabolic Response ofFrontiers in cellular and infection microbiology · 2021
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. IRF5 Is Required for Bacterial Clearance in Human M1-Polarized Macrophages, andJournal of immunology (Baltimore, Md. : 1950) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Andrea PaunSidney Kimmel Comprehensive Center, The Johns Hopkins University, Baltimore, Maryland, United States of America.
Rashmi Bankoti
Trupti Joshi
Paula M Pitha
Simona Stäger
Johns Hopkins University · USJohns Hopkins Medicine · USSidney Kimmel Comprehensive Cancer Center · US

Funding

Innate antiviral response and predisposition to neoplasia in IRF-5 deficient mousR01AI067632 · NIAID · JOHNS HOPKINS UNIVERSITY · PI PITHA-ROWE, PAULA M · 2006 to 2010
$2.2M
NIAID NIH HHS R01 AI067632NIAID NIH HHS R01 AI067632-03
6 · The paper itself

Abstract

The transcription factor Interferon Regulatory Factor 5 (IRF-5) has been shown to be involved in the induction of proinflammatory cytokines in response to viral infections and TLR activation and to play an essential role in the innate inflammatory response. In this study, we used the experimental model of visceral leishmaniasis to investigate the role of IRF-5 in the generation of Th1 responses and in the formation of Th1-type liver granulomas in Leishmania donovani infected mice. We show that TLR7-mediated activation of IRF-5 is essential for the development of Th1 responses to L. donovani in the spleen during chronic infection. We also demonstrate that IRF-5 deficiency leads to the incapacity to control L. donovani infection in the liver and to the formation of smaller granulomas. Granulomas in Irf5⁻/⁻ mice are characterized by an increased IL-4 and IL-10 response and concomitant low iNOS expression. Collectively, these results identify IRF-5 as a critical molecular switch for the development of Th1 immune responses following L. donovani infections and reveal an indirect role of IRF-5 in the regulation of iNOS expression.

Indexed as

Host-Parasite InteractionsAnimalsDisease Models, AnimalFemaleGene ExpressionGranulomaHEK293 CellsHumansInbreedingInterferon Regulatory FactorsLeishmania donovaniLeishmaniasis, VisceralLiverLuciferasesMacrophagesMaleInterferon Regulatory FactorsIrf5 protein, mouseLuciferasesNitric Oxide Synthase Type IINos2 protein, mouseRNA, Messenger

Identifiers

PMID21253574
PMCPMC3017120
OpenAlexW2075534053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.